| General Information of Drug Metabolite (DM) (ID: DM018979) |
| DM Name |
Almonertinib Metabolite HS-10296-M2
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A (CYP3A)
|
DMEN065
|
| Unclear - Unclear |
Almonertinib
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Almonertinib |
DR3496
|
Phase 3 |
Lung cancer |
|
|
| References |
| 1 |
Absorption, metabolism, excretion, and safety of [(14)C]almonertinib in healthy Chinese subjects
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
